Key Takeaways
- • Investor capital is systematically reallocating away from private credit toward private equity and venture capital funds, signaling a shift in semiliquid fund preferences driven by changing market conditions and return expectations.
- • Leverage, redemption limits, and valuation practices are critical structural variables that directly influence semiliquid fund performance and investor outcomes, requiring detailed scrutiny during fund evaluation.
- • Portfolio liquidity management—including cash retention levels, loan maturity profiles, and redemption policies—materially affects an investor's ability to access capital when needed, particularly in stressed market environments.
- • Fee transparency and incentive fee disclosures remain inconsistent across semiliquid fund managers, creating obstacles for institutional investors attempting to conduct meaningful product comparisons.
- • Morningstar's Medalist Ratings framework provides a standardized methodology for evaluating semiliquid funds alongside public market alternatives, offering institutional investors a more disciplined approach to alternative investment selection.
Summary
Moriarty emphasizes that structural characteristics heavily determine semiliquid fund performance and suitability. Key variables include leverage deployment, redemption limits that constrain liquidity access, and valuation methodologies that determine net asset value calculations. These mechanics operate beneath headline return figures and directly impact investor experience, particularly during redemption cycles or market dislocations.
Portfolio management practices constitute another critical evaluation dimension. Moriarty highlights the importance of cash retention policies, loan maturity schedules, and how fund managers structure liquidity reserves to honor redemption requests without forced asset sales. These operational choices become especially consequential when market stress emerges and redemption demand increases simultaneously across the investor base.
Fee structures and incentive compensation disclosure practices remain inconsistent across the semiliquid fund industry. Moriarty notes that varying disclosure standards complicate direct product comparisons and obscure true cost impact for institutional investors. Enhanced transparency in fee documentation would enable more rigorous relative valuation across competing strategies.
Morningstar addresses these evaluation challenges through its Medalist Ratings framework, which applies standardized criteria to semiliquid funds and positions them within a comparable universe that includes public market alternatives. This approach equips institutional investors with a structured methodology for assessing whether semiliquid allocations deliver appropriate risk-adjusted returns relative to liquid public equity, fixed income, and other established asset classes.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.